Schonfeld Strategic Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-69,374
Closed -$515K – 2863
2026
Q1
$515K Buy
+69,374
New +$730K ﹤0.01% 1373
2025
Q3
– Sell
-128,280
Closed -$938K – 2438
2025
Q2
$938K Buy
+128,280
New +$1.04M 0.01% 1328
2025
Q1
– Sell
-16,280
Closed -$268K – 2400
2024
Q4
$268K Sell
16,280
-54,330
-77% -$844K ﹤0.01% 1654
2024
Q3
$1.04M Buy
70,610
+13,170
+23% +$206K 0.01% 1147
2024
Q2
$797K Buy
+57,440
New +$814K 0.01% 1300
2024
Q1
– Sell
-80,930
Closed -$1.31M – 2285
2023
Q4
$1.31M Sell
80,930
-7,478
-8% -$122K 0.01% 944
2023
Q3
$1.09M Sell
88,408
-48,408
-35% -$720K 0.01% 994
2023
Q2
$2.2M Buy
+136,816
New +$2.25M 0.02% 721
2022
Q4
– Sell
-67,100
Closed -$578K – 2871
2022
Q3
$578K Buy
+67,100
New +$666K ﹤0.01% 1651
2018
Q4
– Sell
-60,000
Closed -$921K – 1184
2018
Q3
$921K Buy
+60,000
New +$829K 0.04% 443

Other funds holding NEO

Schonfeld Strategic Advisors's NEO Position: Q2 2026 in Review

Schonfeld Strategic Advisors sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 69,374 shares — an estimated $515K sold.

Schonfeld Strategic Advisors first reported a position in NEO in Q3 2018 and held it in 10 quarters. The position peaked at $2.2M in Q2 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Schonfeld Strategic Advisors reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 69,374 NeoGenomics shares in Q2 2026, an estimated $515K.
  • Schonfeld Strategic Advisors first reported a position in NeoGenomics in Q3 2018 and held it in 10 quarters.
  • Schonfeld Strategic Advisors's NeoGenomics position peaked at $2.2M in Q2 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.